Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-026001
Filing Date
2025-08-29
Accepted
2025-08-29 16:30:52
Documents
1
Period of Report
2025-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6141
  Complete submission text file 0001641172-25-026001.txt   7736
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Issuer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address
Yu Yong (Reporting) CIK: 0001937482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41599 | Film No.: 251281371